Gyrodyne Sets Nov. 5 Shareholder Vote on Director, Exec Pay, Auditor

TL;DR

**GYRO's board is pushing for continuity and rubber-stamping executive pay, so vote 'FOR' their slate if you trust their real estate liquidation strategy.**

AI Summary

Gyrodyne, LLC (GYRO) is holding its annual shareholder meeting on November 5, 2025, at Flowerfield Celebrations in Saint James, New York. Shareholders will vote on three key proposals: the election of Richard B. Smith as a director for a three-year term ending in 2028, a non-binding advisory vote on executive compensation, and the ratification of Baker Tilly US, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. The Board of Directors unanimously recommends voting 'FOR' all three proposals. As of the September 15, 2025 record date, Gyrodyne had 2,199,308 common shares outstanding and entitled to vote. The company emphasizes its commitment to engaging with shareholders and executing its long-term strategic plan to realize shareholder value, which includes efforts to enhance and strategically sell its remaining properties, such as Flowerfield and Cortlandt Manor.

Why It Matters

This DEF 14A filing outlines critical governance decisions for Gyrodyne, LLC, a company actively pursuing the strategic sale of its real estate assets. The election of Richard B. Smith to the board is crucial for maintaining board stability and oversight during this transitional period. The 'Say-on-Pay' vote offers investors a direct channel to influence executive compensation, ensuring alignment with shareholder interests, especially as the company navigates property sales. Ratifying Baker Tilly US, LLP as auditor provides essential financial transparency and accountability, which is vital for investor confidence in a company undergoing significant strategic changes and facing competitive pressures in the New York real estate market.

Risk Assessment

Risk Level: medium — The filing mentions 'risks and uncertainties generally relating to our efforts to enhance the values of our remaining properties and seek the orderly, strategic sale of such properties as soon as reasonably practicable.' It also cites 'risks associated with the Article 78 Proceeding against the Company and any other litigation' and 'community activism risk,' indicating potential hurdles in their core strategy of property sales.

Analyst Insight

Investors should carefully review the full proxy statement, particularly the executive compensation details and the qualifications of Richard B. Smith, before the November 5, 2025 meeting. Given the company's focus on property sales, understanding the board's strategic direction and executive incentives is paramount.

Key Numbers

• 2025-11-05 — Annual Meeting Date (Date shareholders will vote on proposals)
• 2025-09-15 — Record Date (Date for determining shareholders entitled to vote)
• 2,199,308 — Common Shares Outstanding (Number of shares entitled to vote as of September 15, 2025)
• 3 — Director Term (Years) (Length of term for elected director Richard B. Smith)
• 2028 — Director Term End Year (Year Richard B. Smith's term would expire if elected)
• 71 — Richard B. Smith's Age (Age of the director nominee)
• 1997 — Paul L. Lamb's First Director Year (Year Paul L. Lamb first became a director)
• 80 — Paul L. Lamb's Age (Age of the Chairman of the Board)
• 1-800-322-2885 — MacKenzie Partners Toll-Free Number (Contact for proxy solicitation assistance)
• 2025-10-17 — Proxy Materials Availability Date (Date proxy statement and card were first made available)

Key Players & Entities

• Gyrodyne, LLC (company) — Registrant
• Richard B. Smith (person) — Nominee for Director
• Gary J. Fitlin (person) — President and Chief Executive Officer
• MacKenzie Partners, Inc. (company) — Proxy Solicitor
• Baker Tilly US, LLP (company) — Independent Registered Public Accounting Firm
• Peter Pitsiokos (person) — Corporate Secretary
• Jan H. Loeb (person) — Continuing Director
• Nader G.M. Salour (person) — Continuing Director
• Ronald J. Macklin (person) — Continuing Director
• Paul L. Lamb (person) — Non-Continuing Director, Chairman of the Board

FAQ

Risk Factors

• Property Sale and Enhancement Efforts [medium — operational]: The company is actively working to enhance the value of its remaining properties and pursue strategic sales. This includes marketing efforts for Flowerfield and Cortlandt Manor, with potential sales contingent on long-term regulatory approvals.
• Article 78 Proceeding and Litigation [medium — legal]: Gyrodyne is involved in an Article 78 Proceeding and faces potential litigation related to its property enhancement and sale initiatives. These legal challenges could impact the company's operations and financial outcomes.
• Real Estate Market Risks [medium — market]: The company is exposed to risks inherent in the real estate markets of Suffolk and Westchester Counties, New York. Fluctuations in these markets can affect property values and the success of sales efforts.
• Economic Uncertainties [medium — financial]: Ongoing inflation, interest rate uncertainty, and the lingering effects of the 2023 banking crisis pose financial risks. These macroeconomic factors could impact Gyrodyne's financial condition and access to capital.
• Regulatory Contingencies and Enforcement [medium — regulatory]: Purchase and sale agreements for remaining properties may be contingent on years-long regulatory approvals. Additionally, there is a risk of regulatory enforcement actions that could affect the company.
• Community Activism and Shareholder Actions [low — operational]: The company faces risks from community activism and potential actions by activist shareholders, including proxy contests. These can disrupt strategic plans and impact governance.
• COVID-19 Pandemic Residual Effects [low — market]: The potential residual effects of the COVID-19 pandemic continue to be a risk factor, potentially impacting real estate markets and business operations.

Industry Context

Gyrodyne operates within the real estate sector, focusing on enhancing and strategically selling its remaining properties. The industry is subject to market fluctuations, interest rate sensitivity, and evolving regulatory landscapes. Companies in this space often engage in complex transactions requiring significant due diligence and approvals.

Regulatory Implications

Gyrodyne faces regulatory risks related to property sales, including potential long-term contingencies for approvals. The company must also navigate general regulatory enforcement risks and comply with SEC filing requirements like this DEF 14A.

What Investors Should Do

1. Review the proposals carefully, particularly the election of Richard B. Smith and the advisory vote on executive compensation, before the November 5, 2025 meeting.
2. Consider the company's strategy for enhancing and selling its remaining properties, as outlined in the risk factors, when evaluating long-term value.
3. Assess the potential impact of ongoing economic uncertainties (inflation, interest rates) and legal proceedings on Gyrodyne's financial performance and strategic execution.

Key Dates

• 2025-11-05: Annual Shareholder Meeting — Shareholders will vote on director elections, executive compensation, and auditor ratification.
• 2025-09-15: Record Date — Determines which shareholders are eligible to vote at the annual meeting.
• 2028: Director Term End Year — Indicates the expiration year of Richard B. Smith's potential directorship.
• 2025-10-17: Proxy Materials Availability Date — Marks when shareholders received the official proxy statement and voting card.

Glossary

DEF 14A

A proxy statement filed with the SEC by publicly traded companies to solicit shareholder votes for an annual meeting. (This document contains the information shareholders need to make informed voting decisions.)

Forward-Looking Information

Statements about future events or conditions that are based on current expectations and assumptions, and are subject to risks and uncertainties. (Helps investors understand potential future outcomes but also highlights inherent uncertainties in the company's plans.)

Article 78 Proceeding

A type of legal proceeding in New York State used to review the legality of a government agency's or body's decision or action. (Indicates a specific legal challenge Gyrodyne is facing, potentially related to its property development or sales.)

Proxy Contest

A situation where opposing groups solicit proxies from shareholders to gain control of the board of directors or influence corporate policy. (Highlights a potential risk of activist shareholder involvement that could impact Gyrodyne's strategic direction.)

Year-Over-Year Comparison

This filing focuses on the upcoming annual meeting and proposals, including the election of a director and executive compensation. Specific comparative financial metrics to a prior filing are not detailed within this excerpt, but the company's strategic focus on property sales and associated risks are highlighted.

Filing Documents

• gyrllc20251016_def14a.htm (DEF 14A) — 526KB
• i01.jpg (GRAPHIC) — 3KB
• 0001437749-25-031274.txt ( ) — 932KB
• gyro-20241231.xsd (EX-101.SCH) — 4KB
• gyro-20241231_def.xml (EX-101.DEF) — 2KB
• gyro-20241231_lab.xml (EX-101.LAB) — 2KB
• gyro-20241231_pre.xml (EX-101.PRE) — 1KB
• gyrllc20251016_def14a_htm.xml (XML) — 30KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 15 INFORMATION ABOUT YOUR BOARD OF DIRECTORS AND MANAGEMENT 17 REPORT OF THE AUDIT COMMITTEE 19 EXECUTIVE OFFICERS AND SIGNIFICANT EMPLOYEES WHO ARE NOT DIRECTORS 20

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 20 SUMMARY COMPENSATION TABLE 20 NARRATIVE DISCLOSURE TO SUMMARY COMPENSATION TABLE 21 COMPENSATION OF DIRECTORS 24 TRANSACTIONS WITH CERTAIN RELATED PERSONS 26 PROPOSAL 2: NON-BINDING ADVISORY VOTE ON EXECUTIVE COMPENSATION 27 PROPOSAL 3: RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 28 SHAREHOLDER PROPOSALS FOR THE 2026 ANNUAL MEETING 29 ADDITIONAL INFORMATION 30 Other Business 30 Costs of the Solicitation 30 Where You Can Find More Information 30 APPENDIX A 31 2 CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING INFORMATION The statements made in this proxy statement and in other materials the Company has filed or may file with the SEC, in each case that are not historical facts, contain "forward-looking information" within the meaning of the Private Securities Litigation Reform Act of 1995, and Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), which can be identified by the use of forward-looking terminology such as "may," "will," "anticipates," "expects," "projects," "estimates," "believes," "seeks," "could," "should," or "continue," the negative thereof, and other variations or comparable terminology as well as statements regarding the evaluation of liquidation contingencies. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those reflected in such forward-looking statements. Such risks and uncertainties include, but are not limited to, risks and uncertainties generally relating to our efforts to enhance the values of our remaining properties and seek the orderly, strategic sale of such properties as soon as reasonably practicable, risks associated with the Article 78 Proceeding against the Company and any other litigation that may dev

View Full Filing

View this DEF 14A filing on SEC EDGAR